Discussion with Vida-Flo Medical Personnel: Each patient has a one-on-one discussion with our medical staff
[2] From a pharmacological perspective, the mechanisms of action of these medications operate through different pathways and do not directly interfere with one another
This is where MeAgain's GLP-1 app fits in, tracking doses, estimating clearance windows, and sending reminders to support scheduling of labs and procedures
Yet, based on the available studies, semaglutide appears to be more effective in improving glycemic control, as measured by the reduction in the levels of glycated hemoglobin (HbA1c): According to data from the SUSTAIN-FORTE trial, there was a -2.2% reduction in baseline HbA1c with 2mg/weekly semaglutide and 1.9% reduction with 1mg/weekly semaglutide after 40 weeks [21] The AWARD-11 trial revealed a -1.77% reduction in baseline HbA1c with 4.5mg/weekly dulaglutide after 36 weeks [18]
As such, higher chargemaster prices may yield increased profits by increasing payments from private payors